Last reviewed · How we verify
Regimen 2, Course, 1, Cycle C1 — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Regimen 2, Course, 1, Cycle C1 (Regimen 2, Course, 1, Cycle C1) — Baylor College of Medicine.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Regimen 2, Course, 1, Cycle C1 TARGET | Regimen 2, Course, 1, Cycle C1 | Baylor College of Medicine | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Regimen 2, Course, 1, Cycle C1 CI watch — RSS
- Regimen 2, Course, 1, Cycle C1 CI watch — Atom
- Regimen 2, Course, 1, Cycle C1 CI watch — JSON
- Regimen 2, Course, 1, Cycle C1 alone — RSS
Cite this brief
Drug Landscape (2026). Regimen 2, Course, 1, Cycle C1 — Competitive Intelligence Brief. https://druglandscape.com/ci/regimen-2-course-1-cycle-c1. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab